← FDA Drug Approvals (Drugs@FDA)
VENLAFAXINE HYDROCHLORIDE
ANDA · Abbreviated New Drug Application (Generic) · Sponsor: SOMERSET THERAPS LLC · Approved 2021-06-30
Drug application
- FDA Application #
ANDA214609
- Application type
- Abbreviated New Drug Application (Generic)
- Brand name
- VENLAFAXINE HYDROCHLORIDE
- Generic name
- VENLAFAXINE
- Active ingredients
- VENLAFAXINE HYDROCHLORIDE
- Dosage form
- TABLET, EXTENDED RELEASE
- Route
- ORAL
- Marketing status
- Prescription
- Sponsor
- SOMERSET THERAPS LLC
- Manufacturer
- Dr. Reddy's Laboratories Inc.
- First approval
- 2021-06-30
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown